Terms ending in 2040
Every in-force patent on Ceragem Co., Ltd.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,998,508 | Massager Controlling Apparatus and Method Thereof In force · High confidence | Ceragem Co., Ltd. | In force | High confidence | |
| US D1,065,110 | Remote Control of Urinary Incontinence Treatment Device In force · High confidence | Ceragem Co., Ltd. | In force | High confidence | |
| US D1,072,261 | Apparatus for Thermotherapy In force · High confidence | Ceragem Co., Ltd. | In force | High confidence | |
| US D1,080,834 | Air Purifier In force · High confidence | Ceragem Co., Ltd. | In force | High confidence | |
| US D1,085,439 | Skin Aesthetic Apparatus In force · High confidence | Ceragem Co., Ltd. | In force | High confidence | |
| US D1,091,851 | Skin Aesthetic Apparatus In force · High confidence | Ceragem Co., Ltd. | In force | High confidence | |
| US D1,091,852 | Skin Aesthetic Apparatus In force · High confidence | Ceragem Co., Ltd. | In force | High confidence | |
| US D1,093,642 | Skin Aesthetic Apparatus In force · High confidence | Ceragem Co., Ltd. | In force | High confidence | |
| US D1,093,924 | Massage chair In force · High confidence | Ceragem Co., Ltd. | In force | High confidence | |
| US D1,094,745 | Side Frame of Thermotherapy Apparatus In force · High confidence | Ceragem Co., Ltd. | In force | High confidence | |
| 8 more term ends in 2040 · Pro | |||||
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.